ArticleOncotarget2016

Kinetics, prognostic and predictive values of ESR1 circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor.

Florian Clatot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.